Table Info

Table 3.

MoCA scores: baseline and outcome of treatment

MoCA scores	Baseline			Outcome
MoCA scores	Min-max	Mean	SD	Min-max	Mean	SD
Visuospatial/executive	0–5	3.87	1.25	1–5	4.10	1.19
Naming	1–3	2.92	0.33	1–3	2.93	0.28
Attention	0–6	4.73	1.35	0–6	4.78	1.35
Language	0–3	2.06	0.93	0–3	2.31	0.87
Abstraction	0–2	1.33	0.82	0–2	1.48	0.74
Delayed recall	0–5	3.15	1.62	0–5	3.75	1.40
Orientation	4–6	5.91	0.34	2–6	5.91	0.46
Total scores	10–30	24.20	4.14	11–30	25.59	4.11

Declarations

Author contributions

AIDSD: Conceptualization, Formal analysis, Writing—original draft, Writing—review & editing. TPP and EGR: Conceptualization, Formal analysis, Writing—review & editing. EPJ: Formal analysis, Writing—review & editing. GCA and AZA: Formal analysis, Writing—review & editing. All authors contributed to the manuscript revision, read, and approved the submitted version.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

This study was approved by the Medical Research Ethics Committee of Cantabria (CEIm) with reference number 2022.241. This study was conducted in accordance with the Declaration of Helsinki principles.

Consent to participate

Informed consent to participate in the study was obtained from all participants.

Consent to publication

Not applicable.

Availability of data and materials

Not applicable.

Funding

Not applicable.

Copyright

References

Mental illness [Internet]. Bethesda (MD): National Institute of Mental Health; [cited 2022 Sep 12]. Available from: https://www.nimh.nih.gov/health/statistics/mental-illness

Morozova A, Zorkina Y, Abramova O, Pavlova O, Pavlov K, Solovevа K, et al. Neurobiological highlights of cognitive impairment in psychiatric disorders. Int J Mol Sci. 2022;23:1217. [DOI] [PubMed] [PMC]

Nakagome K. Cognitive impairment in psychiatric disorders. Psychiatry Clin Neurosci. 2017;71:293. [DOI] [PubMed]

Bora E, Yücel M, Pantelis C. Cognitive impairment in affective psychoses: a meta-analysis. Schizophr Bull. 2010;36:112–25. [DOI] [PubMed] [PMC]

Bora E, Yucel M, Pantelis C. Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study. Br J Psychiatry. 2009;195:475–82. [DOI] [PubMed]

MacQueen GM, Memedovich KA. Cognitive dysfunction in major depression and bipolar disorder: assessment and treatment options. Psychiatry Clin Neurosci. 2017;71:18–27. [DOI] [PubMed]

McCleery A, Nuechterlein KH. Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations. Dialogues Clin Neurosci. 2019;21:239–48. [DOI] [PubMed] [PMC]

Reichenberg A, Harvey PD, Bowie CR, Mojtabai R, Rabinowitz J, Heaton RK, et al. Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophr Bull. 2009;35:1022–9. [DOI] [PubMed] [PMC]

Zhu Y, Womer FY, Leng H, Chang M, Yin Z, Wei Y, et al. The relationship between cognitive dysfunction and symptom dimensions across schizophrenia, bipolar disorder, and major depressive disorder. Front Psychiatry. 2019;10:253. [DOI] [PubMed] [PMC]

10.

Solé B, Jiménez E, Torrent C, Reinares M, Del Mar Bonnin C, Torres I, et al. Cognitive impairment in bipolar disorder: treatment and prevention strategies. Int J Neuropsychopharmacol. 2017;20:670–80. [DOI] [PubMed] [PMC]

11.

Tsapekos D, Strawbridge R, Cella M, Wykes T, Young AH. Cognitive impairment in euthymic patients with bipolar disorder: prevalence estimation and model selection for predictors of cognitive performance. J Affect Disord. 2021;294:497–504. [DOI] [PubMed]

12.

Bourne C, Aydemir Ö, Balanzá-Martínez V, Bora E, Brissos S, Cavanagh JT, et al. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand. 2013;128:149–62. [DOI] [PubMed]

13.

Daniel BD, Montali A, Gerra ML, Innamorati M, Girardi P, Pompili M, et al. Cognitive impairment and its associations with the path of illness in affective disorders: a comparison between patients with bipolar and unipolar depression in remission. J Psychiatr Pract. 2013;19:275–87. [DOI] [PubMed]

14.

Rock PL, Roiser JP, Riedel WJ, Blackwell AD. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2014;44:2029–40. [DOI] [PubMed]

15.

Mihaljeviü-Peleš A, Bajs Janović M, Šagud M, Živkoviü M, Janoviü Š, Jevtović S. Cognitive deficit in schizophrenia: an overview. Psychiatr Danub. 2019;31:139–42. [PubMed]

16.

Vita A, Gaebel W, Mucci A, Sachs G, Erfurth A, Barlati S, et al. European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia. Eur Psychiatry. 2022;65:e58. [DOI] [PubMed] [PMC]

17.

Helzer JE, Kraemer HC, Krueger RF. The feasibility and need for dimensional psychiatric diagnoses. Psychol Med. 2006;36:1671–80. [DOI] [PubMed]

18.

Ruggero CJ, Kotov R, Hopwood CJ, First M, Clark LA, Skodol AE, et al. Integrating the Hierarchical Taxonomy of Psychopathology (HiTOP) into clinical practice. J Consult Clin Psychol. 2019;87:1069–84. [DOI] [PubMed] [PMC]

19.

Dalgleish T, Black M, Johnston D, Bevan A. Transdiagnostic approaches to mental health problems: current status and future directions. J Consult Clin Psychol. 2020;88:179–95. [DOI] [PubMed] [PMC]

20.

Guía de Gestión del hospital de día psiquiátrico [Internet]. Madrid: Instituto Nacional de Gestión Sanitaria; c2020 [cited 2022 Nov 25]. Available from: https://ingesa.sanidad.gob.es/bibliotecaPublicaciones/publicaciones/internet/psiquiatrico.htm

21.

Vázquez Bourgon J, Lastra IL, Artal Simón J, Crespo Facorro B, Vázquez-Barquero JL. Plan Funcional de la Unidad de Hospitalización Psiquiátrica Parcial. Servicio de Psiquiatría, Hospital Universitario Marqués de Valdecilla, editors. Santander: Imprenta Regional del Gobierno de Cantabria; 2014. Spanish.

22.

Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–9. [DOI] [PubMed]

23.

Lobo A, Chamorro L, Luque A, Dal-Ré R, Badia X, Baró E, et al. Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales. Med Clin (Barc). 2002;118:493–9. Spanish. [DOI] [PubMed]

24.

Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429–35. [DOI] [PubMed]

25.

Colom F, Vieta E, Martínez-Arán A, Garcia-Garcia M, Reinares M, Torrent C, et al. Spanish version of a scale for the assessment of mania: validity and reliability of the Young Mania Rating Scale. Med Clin (Barc). 2002;119:366–71. Spanish. [DOI] [PubMed]

26.

Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50–5. [DOI] [PubMed]

27.

Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep. 1962;10:799–812. [DOI]

28.

Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9. [DOI] [PubMed]

29.

Ojeda N, del Pino R, Ibarretxe-Bilbao N, Schretlen DJ, Peña J. Montreal cognitive assessment test: normalization and standardization for Spanish population. Rev Neurol. 2016;63:488–96. Spanish. [PubMed]

30.

Rosa AR, Sánchez-Moreno J, Martínez-Aran A, Salamero M, Torrent C, Reinares M, et al. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Heal. 2007;3:5. [DOI] [PubMed] [PMC]

31.

Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull. 1988;24:653–9. [PubMed]

32.

Brooks R; EuroQol Group. EuroQol: the current state of play. Health Policy. 1996;37:53–72. [DOI] [PubMed]

33.

Badia X, Monserrat S, Roset M, Herdman M. Feasibility, validity and test–retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off. Qual Life Res. 1999;8:303–10. [DOI] [PubMed]

34.

Shafer A. Meta-analysis of the Brief Psychiatric Rating Scale factor structure. Psychol Assess. 2005;17:324–35. [DOI] [PubMed]

35.

Subdirección General de Información Sanitaria. Salud mental en datos: prevalencia de los problemas de salud y consumo de psicofármacos y fármacos relacionados a partir de registros clínicos de atención primaria. Madrid: Ministerio de Sanidad; 2021. Spanish.